AOTMiT: On Monday, the Transparency Council will deal with, inter alia, infertility, HIV and schizophrenia

The agenda for the Transparency Council (02/14) includes:

• Preparation of an opinion on the validity of introducing Vocabria (cabotegravir), used in combination with rilpivirine, into the health policy program "Antiretroviral treatment of people living with HIV in Poland".
• Preparation of a position on the legitimacy of granting consent for the reimbursement of Perphenazin-Neuraxpharm (perphenazin) in the indication: paranoid schizophrenia.
• Preparation of an opinion on the draft health policy program of the local government unit "Support for couples, especially men, requiring highly specialized care and immunological and genetic infertility diagnostics along with insemination support for residents of the city of Szczecin for the years 2022-2026".

Assessment of drug technologies in terms of their innovation.

Source: AOTMiT